These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6732543)

  • 1. Evaluation of the influence of peritoneal dialysis on cellular immunity by the E-rosette inhibition test.
    Giacchino F; Pozzato M; Piccoli G
    Artif Organs; 1984 May; 8(2):156-60. PubMed ID: 6732543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rosette E and active rosette E tests in the evaluation of cell-mediated immunity in uremic patients].
    Giacchino F; Giachino G; Giraudo G; Boero R; Basolo B; Bancale E; Nigra M; Piccoli GB; Piccoli G
    Arch Sci Med (Torino); 1982; 139(1):19-22. PubMed ID: 7103704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of haemo- and peritoneal dialysis on the cell-mediated immune response in chronic uraemia.
    Németh L; Gofman L; Karátson A; Hámori A
    Int Urol Nephrol; 1980; 12(4):375-84. PubMed ID: 6763011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous ambulatory peritoneal dialysis and cellular immunity.
    Giangrande A; Cantù P; Limido A; de Francesco D; Malacrida V
    Proc Eur Dial Transplant Assoc; 1983; 19():372-9. PubMed ID: 6603616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of uremia and dialysis on cell-mediated immunity.
    Wojtulewicz-Kurkus J; Klepacka J; Skopińska E; Górski A; Nowaczyk M; Orłowski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):997-1000. PubMed ID: 86344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of larger molecules on cellular response in uremia.
    Giacchino F; Quarello F; Pozzato M; Giraudo G; Formica M; Quattrocchio G; Piccoli G
    Trans Am Soc Artif Intern Organs; 1983; 29():29-32. PubMed ID: 6608816
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperlipidemia in uremic children: response to peritoneal dialysis and hemodialysis.
    Berger M; James GP; Davis ER; Jasper PM; Brouhard BH; Travis LB; Cunningham RJ
    Clin Nephrol; 1978 Jan; 9(1):19-24. PubMed ID: 343952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of uremic serum on E-rosette formation of normal lymphocytes modulated by levamisole.
    Modai D; Peller S; Weissgarten J; Shaked U; Kaufman S
    Isr J Med Sci; 1981 Dec; 17(12):1115-8. PubMed ID: 7327910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of the dinitrochlorobenzene test in evaluation of cellular immunity in uremic patients].
    Giacchino F; Triolo G; Coppo R; Alloatti S; Quarello F; Rotunno M; Martini PF; Segoloni G; Piccoli G; Vercellone A
    Minerva Nefrol; 1979; 26(3):343-8. PubMed ID: 318059
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemodialysis, continuous ambulatory peritoneal dialysis and cellular immunity.
    Collart F; Tielemans C; Dratwa M; Schandene L; Wybran J; Dupont E
    Proc Eur Dial Transplant Assoc; 1983; 20():190-4. PubMed ID: 6228939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibitory influence of dialysis treatment on E-rosette formation.
    Giacchino F; Alloatti S; Belardi P; Coppo R; Giraudo G; Bosticardo GM; Pozzato M; Piccoli G
    Trans Am Soc Artif Intern Organs; 1982; 28():594-8. PubMed ID: 7164309
    [No Abstract]   [Full Text] [Related]  

  • 12. Rosette-inhibiting activity of uraemic sera and the influence of dialysis.
    Rowiński W; Lukasiewicz H; Orlowski T; Sluźewska W
    Proc Eur Dial Transplant Assoc; 1972; 9():507-13. PubMed ID: 4677520
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunologic reactivity in uremic patients in hemodialysis].
    Rotolo U
    Recenti Prog Med; 1979 Feb; 66(2):116-23. PubMed ID: 312517
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis.
    Salvati F; Liani M
    Int J Artif Organs; 2001 Mar; 24(3):131-5. PubMed ID: 11314805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The peripheral T and B lymphocytes in uremic patients.
    Sobczyk J
    Arch Immunol Ther Exp (Warsz); 1979; 27(5):681-6. PubMed ID: 317640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Further investigations on cellular immunodeficiency in uraemic patients and the effect of haemodialysis (author's transl)].
    Reis HE; Cremer W; Heimsoth VH; Graffe-Achelis C; Wetter O
    Klin Wochenschr; 1975 May; 53(10):467-72. PubMed ID: 1195651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MLC-blocking factors in uremic sera.
    Fehrman I; Ringdén O; Bergström J
    Clin Nephrol; 1980 Oct; 14(4):183-9. PubMed ID: 7000408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood folates in chronic uremic patients in dialysis treatment].
    Chelazzi G; Bernasconi G; Gastaldi L; Martegani M; Fachinetti A; Giuliani F
    Minerva Med; 1980 Oct; 71(42):3073-86. PubMed ID: 7022266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological aspects of chronic uremia.
    Casciani CU; De Simone C; Bonini S; Gallucci MT; Matteucci G; Valesini G; Meli D; Masala C
    Kidney Int Suppl; 1978 Jun; (8):S49-54. PubMed ID: 278897
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of zinc on cellular immunity in chronic uremia.
    Antoniou LD; Shalhoub RJ; Schechter GP
    Am J Clin Nutr; 1981 Sep; 34(9):1912-7. PubMed ID: 7282617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.